Search Results - "Fujieda, Y"

Refine Results
  1. 1
  2. 2
  3. 3

    Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study by Hisada, R., Kato, M., Sugawara, E., Fujieda, Y., Oku, K., Bohgaki, T., Amengual, O., Yasuda, S., Atsumi, T.

    Published in Journal of thrombosis and haemostasis (01-09-2017)
    “…Essentials Thrombotic risk stratification is an unmet need in antiphospholipid antibody carriers. Platelet count and antiphospholipid score (aPL‐S) were…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Pregnancy outcomes in women with rheumatic diseases: a real-world observational study in Japan by Sugawara, E, Kato, M, Fujieda, Y, Oku, K, Bohgaki, T, Yasuda, S, Umazume, T, Morikawa, M, Watari, H, Atsumi, T

    Published in Lupus (01-10-2019)
    “…Objectives We aimed to evaluate the obstetric complications and the risk factors for these events in pregnant women with rheumatic diseases (RDs). Methods A…”
    Get full text
    Journal Article
  6. 6

    Factor Xa inhibitors for preventing recurrent thrombosis in patients with antiphospholipid syndrome: a longitudinal cohort study by Sato, T, Nakamura, H, Fujieda, Y, Ohnishi, N, Abe, N, Kono, M, Kato, M, Oku, K, Bohgaki, T, Amengual, O, Yasuda, S, Atsumi, T

    Published in Lupus (01-11-2019)
    “…Objective The objective of this study was to clarify the efficacy and safety of factor Xa inhibitors for antiphospholipid syndrome patients in real world…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Long-term outcome in Japanese patients with lupus nephritis by Kono, M, Yasuda, S, Kato, M, Kanetsuka, Y, Kurita, T, Fujieda, Y, Otomo, K, Horita, T, Oba, K, Kondo, M, Mukai, M, Yanai, M, Fukasawa, Y, Atsumi, T

    Published in Lupus (01-10-2014)
    “…The objective of this study was to clarify the long-term outcome in patients with lupus nephritis (LN) according to the International Society of Nephrology and…”
    Get full text
    Journal Article
  9. 9

    Role of apolipoprotein B100 and oxidized low-density lipoprotein in the monocyte tissue factor induction mediated by anti-β2 glycoprotein I antibodies by Otomo, K, Amengual, O, Fujieda, Y, Nakagawa, H, Kato, M, Oku, K, Horita, T, Yasuda, S, Matsumoto, M, Nakayama, K I, Hatakeyama, S, Koike, T, Atsumi, T

    Published in Lupus (01-10-2016)
    “…Objective The objective of this paper is to elucidate the not yet known plasma molecule candidates involved in the induction of tissue factor (TF) expression…”
    Get full text
    Journal Article
  10. 10

    Resistance exercise enhances cognitive function in mouse by Suijo, K, Inoue, S, Ohya, Y, Odagiri, Y, Takamiya, T, Ishibashi, H, Itoh, M, Fujieda, Y, Shimomitsu, T

    Published in International journal of sports medicine (01-04-2013)
    “…Physical exercise has been shown to increase adult neurogenesis in the hippocampus and to enhance synaptic plasticity. It has been demonstrated that these…”
    Get more information
    Journal Article
  11. 11

    Predominant prevalence of arterial thrombosis in Japanese patients with antiphospholipid syndrome by Fujieda, Y, Atsumi, T, Amengual, O, Odani, T, Otomo, K, Kato, M, Oku, K, Kon, Y, Horita, T, Yasuda, S, Koike, T

    Published in Lupus (01-12-2012)
    “…Objective: To study the clinical and immunological manifestations of antiphospholipid syndrome (APS) in the Japanese population by a single-centre…”
    Get full text
    Journal Article
  12. 12

    The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review by Kato, M, Kataoka, H, Odani, T, Fujieda, Y, Otomo, K, Oku, K, Horita, T, Yasuda, S, Atsumi, T, Ohira, H, Tsujino, I, Nishimura, M, Koike, T

    Published in Lupus (01-10-2011)
    “…Pulmonary arterial hypertension (PAH) is a life-threatening complication in connective tissue diseases (CTD). It remains controversial whether…”
    Get full text
    Journal Article
  13. 13

    The involvement of CD36 in monocyte activation by antiphospholipid antibodies by Kato, M, Atsumi, T, Oku, K, Amengual, O, Nakagawa, H, Fujieda, Y, Otomo, K, Horita, T, Yasuda, S, Koike, T

    Published in Lupus (01-07-2013)
    “…Background CD36, known as a scavenger receptor, is a transmembrane glycoprotein expressed on monocytes, platelets and endothelial cells, recognizes multiple…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Up-regulated expression of HLA-DRB5 transcripts and high frequency of the HLA-DRB501:05 allele in scleroderma patients with interstitial lung disease by ODANI, Toshio, YASUDA, Shinsuke, OTA, Yuko, FUJIEDA, Yuichiro, KON, Yujiro, HORITA, Tetsuya, KAWAGUCHI, Yasushi, ATSUMI, Tatsuya, YAMANAKA, Hisashi, KOIKE, Takao

    Published in Rheumatology (Oxford, England) (01-10-2012)
    “…Interstitial lung disease (ILD) is a serious complication of SSc. We aimed to identify markers associated with SSc-related ILD. RNA was prepared from the…”
    Get full text
    Journal Article
  18. 18

    Role of apolipoprotein B100 and oxidized low-density lipoprotein in the monocyte tissue factor induction mediated by anti- beta 2 glycoprotein I antibodies by Otomo, K, Amengual, O, Fujieda, Y, Nakagawa, H, Kato, M, Oku, K, Horita, T, Yasuda, S, Matsumoto, M, Nakayama, K I, Hatakeyama, S, Koike, T, Atsumi, T

    Published in Lupus (01-10-2016)
    “…Objective The objective of this paper is to elucidate the not yet known plasma molecule candidates involved in the induction of tissue factor (TF) expression…”
    Get full text
    Journal Article
  19. 19

    272 Clinical significance of anti-dna/nr2 antibodies in de novo npsle and post-steroid npsle by Fujieda, Y, Mader, S, Jegnathan, V, Arimuna, Y, Shimizu, Y, Kato, M, Oku, K, Bohgaki, T, Amengual, O, Yasuda, S, Diamond, B, Atsumi, T

    Published in Lupus science & medicine (01-03-2017)
    “…Background and aimsAnti-DNA/NR2 antibodies are a subset of anti DNA autoantibodies that cross-react with the extracellular domain of the GluN2A/GluN2B subunits…”
    Get full text
    Journal Article
  20. 20

    29 Antiphospholipid score is a novel risk factor for idiopathic osteonecrosis by Ohnishi, N, Kato, M, Ogata, Y, Abe, S, Kono, M, Shibata, Y, Tanimura, S, Hisada, R, Doi, M, Fujieda, Y, Oku, K, Bohgaki, T, Amengual, O, Yasuda, S, Atsumi, T

    Published in Lupus science & medicine (01-03-2017)
    “…Background and AimsOur group introduced a quantitative marker of antiphospholipid antibodies (aPL) ‘‘antiphospholipid score (aPL-S)’’, which well reflected the…”
    Get full text
    Journal Article